Elsevier

World Neurosurgery

Volume 138, June 2020, Pages e336-e344
World Neurosurgery

Original Article
Regional Variance in Disability and Quality-of-Life Outcomes After Surgery for Grade I Degenerative Lumbar Spondylolisthesis: A Quality Outcomes Database Analysis

https://doi.org/10.1016/j.wneu.2020.02.117Get rights and content

Objective

Regional differences in outcomes after spine surgery are poorly understood. We assessed disability and quality-of-life outcomes by geographic region in the United States using the NeuroPoint Alliance Quality Outcomes Database.

Methods

We queried the prospective Quality Outcomes Database patient registry to identify patients who underwent elective 1- or 2-level lumbar surgery for grade I degenerative spondylolisthesis from July 2014 through June 2016. Primary outcome measures included Oswestry Disability Index (ODI) and EuroQOL-5D (EQ-5D) reported at 24 months postoperatively. Differences in EQ-5D and ODI were compared across geographic regions of the United States (Northeast, Midwest, South, West).

Results

We identified 608 patients from 12 centers who underwent surgery. Of these, 517 (85.0%) had ODI data and 492 (80.9%) had EQ-5D data at 24 months. Southern states had the largest representation (304 patients; 5 centers), followed by Northeastern (114 patients; 3 centers), Midwestern (96 patients; 2 centers), and Western (94 patients; 2 centers) states. Baseline ODI scores were significantly different among regions, with the South having the greatest baseline disability burden (Northeast: 40.9 ± 16.9, South: 51.2 ± 15.8, Midwest: 40.9 ± 17.8, West: 45.0 ± 17.1, P < 0.001). The change in ODI at 24 months postoperatively was significantly different among regions, with the South showing the greatest ODI improvement (Northeast: −21.1 ± 18.2, South: −26.5 ± 20.2, Midwest: −18.2 ± 22.9, West: −21.7 ± 19.6, P < 0.001). All regions had ≥60% achievement of the minimum clinically important difference in ODI at 24 months postoperatively. No regional differences were observed for EQ-5D.

Conclusion

Significant regional variation exists for disability outcomes, but not quality of life, at 24 months after spinal surgery for grade I degenerative spondylolisthesis.

Introduction

Lumbar degenerative disease is a pervasive cause of disability and pain, with lumbar stenosis affecting more than 200,000 adults in the United States (US)1 and lumbar spondylolisthesis affecting 11.5% of the US population.2 Surgical interventions including decompressive laminectomy with or without instrumentation and fusion may be indicated in patients who have failed conservative medical management of symptomatic lumbar spondylolisthesis.3,4 Importantly, the Spine Patient Outcomes Research Trial demonstrated that surgery for degenerative lumbar disease improved health and decreased cost per quality-adjusted life year compared with medical management alone.5 After recent health policy reforms, increased emphasis has been placed on value-based medical care, including patient outcomes after surgery for degenerative lumbar disease.6

Regional variations in lumbar spinal surgery techniques/rates,7, 8, 9 costs,10,11 pain control regimens,12 and patient outcomes10 have been studied previously. Prior studies have also investigated quality-of-life differences between international cohorts 13,14; however, to our knowledge, no study has specifically investigated regional differences in patient disability or quality of life at long-term follow-up. As multi-institutional patient registries and multicenter studies have become more commonplace, regional differences in outcome measures reported in such studies are potentially under-reported and may affect how results from such studies are interpreted.

The Neuropoint Alliance Quality Outcomes Database (QOD) is a prospective, longitudinal, multicenter patient registry developed specifically to study patient outcomes after neurosurgical intervention.15 Since the formation of the Neuropoint alliance in 2008, the QOD has collected perioperative data as well as postoperative follow-up information at each participating site. Institutions from across the US are represented in the QOD data set, with a total of 12 participating high-volume sites with representation from each of the 4 mainland US Census Bureau geographic regions (Northeast, South, Midwest, West).

The objective of this study was to analyze regional variation in disability and quality-of-life outcomes after 1- or 2-level decompression and/or fusion for grade 1 spondylolisthesis using the multi-institutional QOD.

Section snippets

Data Source

The QOD is the first neurosurgical specialty–specific multicenter database with an initial focus on spine procedures and outcomes, and it contains de-identified patient data. Prior studies have thoroughly described the QOD data collection methodology.15, 16, 17, 18 Each participating site had institutional review board approval to enroll patients for data collection. Twelve sites from across the US were included in this retrospective review of the prospective database (the 12 highest enrolling

Results

Six hundred eight patients from 12 centers were included. Of these, 517 patients (85.0%) had ODI data and 492 patients (80.9%) had EQ-5D data at 24 months. Southern states had the largest representation (304 patients; 5 centers) followed by Northeastern (114 patients; 3 centers), Midwestern (96 patients; 2 centers), and Western (94 patients; 2 centers) states.

Table 1 displays patient baseline variables across geographic region. Age at surgery (patients in Northeast and Western regions tended to

Discussion

Patient disability and quality of life after surgical intervention for lumbar degenerative disease are crucial metrics of surgical success. To our knowledge, no prior study had reported regional variation in disability and quality-of-life outcomes after surgery for degenerative lumbar spondylolisthesis. In a cohort of 498 patients from all 4 major geographic regions of the US from a high-quality, neurosurgery-specific, prospective patient registry, we report significant regional variation in

Conclusions

Significant regional variation exists for disability outcomes, but not quality of life, at 24 months after spinal surgery for grade I degenerative spondylolisthesis. Patients from Southern states have the highest baseline disability burden but show the greatest improvement disability at postoperative follow-up. Despite regional variation in disability outcomes, overall improvement in both disability and quality of life was seen across regions and were sustained at long-term follow-up. These

CRediT authorship contribution statement

Brandon A. Sherrod: Conceptualization, Data curation, Writing - original draft, Writing - review & editing. Praveen V. Mummaneni: Conceptualization, Data curation, Writing - review & editing. Mohammed Ali Alvi: Data curation, Writing - review & editing. Andrew K. Chan: Data curation, Writing - review & editing. Mohamad Bydon: Data curation, Writing - review & editing. Steven D. Glassman: Data curation, Writing - review & editing. Kevin T. Foley: Data curation, Writing - review & editing. Eric

Acknowledgment

We would like to thank Kristin Kraus for editorial assistance.

References (30)

  • O. Adogwa et al.

    Cost per quality-adjusted life year gained of revision neural decompression and instrumented fusion for same-level recurrent lumbar stenosis: defining the value of surgical intervention

    J Neurosurg Spine

    (2012)
  • M. Raad et al.

    Trends in isolated lumbar spinal stenosis surgery among working US adults aged 40-64 years, 2010-2014

    J Neurosurg Spine

    (2018)
  • M. Raad et al.

    US regional variations in rates, outcomes, and costs of spinal arthrodesis for lumbar spinal stenosis in working adults aged 40-65 years

    J Neurosurg Spine

    (2018)
  • J.N. Weinstein et al.

    Trends and geographic variations in major surgery for degenerative diseases of the hip, knee, and spine

    Health Aff (Millwood)

    (2004)
  • C. Ames et al.

    Geographic and ethnic variations in radiographic disability thresholds: analysis of North American and Japanese operative adult spinal deformity populations

    Neurosurgery

    (2016)
  • Cited by (0)

    Conflict of interest statement: A. K. Chan receives research support for unrelated research from Orthofix. P. V. Mummaneni has been a consultant for DePuy Spine, Globus, and Stryker; owns stock in Spinicity/ISD; clinical/research support for this study from NREF; receives royalties from DePuy Spine, Thieme, and Springer; and has received honoraria from AOSpine and Spineart. S. D. Glassman is an employee of Norton Healthcare and holds a patent with, has been a consultant for, and receives royalties from Medtronic. K. T. Foley has been a consultant for, receives royalties from, holds a patent with, and owns stock in Medtronic; owns stock in and holds a patent with NuVasive; owns stock in and is a member of the board of directors for Discgenics and TrueVision; and owns stock in Spine Wave. E. A. Potts has been a consultant for Medtronic. D. Coric has been a consultant for Spine Wave, Stryker, Medtronic, Globus Medical, and Premia Spine and owns stock in Spine Wave and Premia Spine. J. J. Knightly has a personal relationship with National Physicians Alliance board of directors. P. Park has been a consultant for Globus, Medtronic, NuVasive, and Zimmer-Biomet and receives royalties from Globus. K.-M. Fu has been a consultant for SI-BONE. J. R. Slotkin has been a consultant for Stryker and Medtronic. E. F. Bisson owns stock in NView; receives fellowship funding from Globus; and receives funding from PCORI.

    View full text